GlaxoSmithKline’s Avandia diabetes drug got hit with a double whammy from regulators on both sides of the pond Thursday. The European Medicines Agency announced plans to yank the drug from the market in the coming months, while U.S. officials placed greater restrictions on its use.
Continue reading Diabetes Drug Avandia Gets No Sugar from Regulators
Diabetes Drug Avandia Gets No Sugar from Regulators originally appeared on DailyFinance on Thu, 23 Sep 2010 20:00:00.
Filed Under: Health Care, GlaxoSmithKline